Artelo Biosciences【ARTL】銘柄情報

Artelo Biosciences Inc (ARTL) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.3108

( 0.83% )

買値

1.32

売値

1.35

出来高

232,508

1.26 日の範囲 1.35

1.05 52 週間の範囲 28.60

時価総額

1.23M

前日終値

1.30

始値

1.31

時刻

1.3481

最終取引時間

05:41:55

財務取引量

US$ 302,940

VWAP

1.3029

平均取引量 (3 か月)

US$ 3,429,818

発行済株式数

938,133

配当利回り

PER

-0.08

1 株当たり利益 (EPS)

-28.02

歳入

純利益

-13.47M

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which... Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

artelobio.com

本社

Solana Beach, United States

設立

2026

Artelo Biosciences Inc is listed in the Healthcare sector of the ナスダック市場 with ticker ARTL. The last closing price for Artelo Biosciences was US$1.30. Over the last year, Artelo Biosciences shares have traded in a share price range of US$ 1.05 to US$ 28.60.

Artelo Biosciences currently has 938,133 shares in issue. The market capitalisation of Artelo Biosciences is US$1.23 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.08.

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success

SOLANA BEACH, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0992	-7.03546099291	1.41	1.5396	1.27	376200	1.35052534	CS
4	-0.9892	-43.0086956522	2.3	2.44	1.19	3173485	1.53418289	CS
12	-5.3892	-80.4358208955	6.7	19.9099	1.19	3653046	6.38537171	CS
26	-0.5992	-31.3717277487	1.91	19.9099	1.05	2219157	6.50264673	CS
52	0.2108	19.1636363636	1.1	28.6	1.05	1412498	6.86165852	CS
156	-0.7092	-35.1089108911	2.02	28.6	0.8196	542698	6.12907778	CS
260	0.1108	9.23333333333	1.2	28.6	0.2599	875594	2.90804485	CS